Pathogenicity of <i>P. gingivalis</i> strains carrying clusters of specific polymorphic variants of peptidylarginine deiminase gene. [PDF]
Strzelec K +17 more
europepmc +1 more source
Regulation of basal and tumour necrosis factor α-induced fibroblast gene expression by peptidylarginine deiminase 2. [PDF]
Saifi MA +6 more
europepmc +1 more source
Microbiome-innate immune crosstalk in acute exacerbation of idiopathic pulmonary fibrosis: an amplification framework. [PDF]
Zhang W, Yi J, Li Z.
europepmc +1 more source
Potential roles and mechanisms of bacterial peptidylarginine deiminase in dental biofilm mediated by <i>Porphyromonas gingivalis</i>. [PDF]
Chen Y, Lou J, Fang Y, Ying S.
europepmc +1 more source
The Association Between Serum Immunoglobulin G Titers Against Porphyromonas gingivalis and Chronic Kidney Disease in Patients With Rheumatoid Arthritis and Periodontitis: A Retrospective Cohort Study. [PDF]
Kobayashi T +5 more
europepmc +1 more source
Related searches:
Peptidylarginine deiminases 4 as a promising target in drug discovery
European Journal of Medicinal Chemistry, 2021Peptidylarginine deaminase 4 (PAD4) is a crucial post-translational modifying enzyme catalyzing the conversion of arginine into citrulline residues, and mediating the formation of neutrophil extracellular traps (NETs). PAD4 plays a vital role in the occurrence and development of cardiovascular diseases, autoimmune diseases, and various tumors ...
Chao, Yang +6 more
openaire +2 more sources
Role of Peptidylarginine Deiminase 4 in Central Nervous System Diseases
Molecular Neurobiology, 2023The deimination or citrullination of arginine residues in the polypeptide chain by peptidylarginine deiminase 4 alters the charge state of the polypeptide chain and affects the function of proteins. It is one of the main ways of protein post-translational modifications to regulate its function.
Yanming Wang, Lai Wang, Wang Yanming
exaly +3 more sources
Peptidylarginine deiminase 4 and citrullination in health and disease
Autoimmunity Reviews, 2010Deimination is catalyzed by a family of calcium binding enzymes, called peptidylarginine deiminases (PADs). Among these, the PAD4 isoform has been more extensively studied for its role in some autoimmune diseases. PAD4 is localized in the cytoplasm of monocytes, T and B cells, neutrophils, eosinophils and NK cells and can move to the nucleus upon cell ...
ANZILOTTI C +3 more
openaire +2 more sources
Novel Peptidylarginine Deiminase Type 4 (PAD4) Inhibitors
ACS Medicinal Chemistry Letters, 2022Provided herein are novel compounds as peptidylarginine deiminase type 4 (PAD4) inhibitors, pharmaceutical compositions, use of such compounds in treating diseases, and processes for preparing such compounds.
openaire +2 more sources
Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors
Molecular Carcinogenesis, 2005AbstractPeptidylarginine deiminase type 4 (PAD4/PADI4) posttranslationally converts peptidylarginine to citrulline, in a process known as citrullination. Evidence suggests that PAD4 plays an essential role in pathogenesis of rheumatoid arthritis (RA).
Xiaotian, Chang, Jinxiang, Han
openaire +2 more sources

